ARS Pharmaceuticals Inc (NASDAQ:SPRY)

7.11
Delayed Data
As of Feb 03
 +0.06 / +0.85%
Today’s Change
2.80
Today|||52-Week Range
9.17
-16.65%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ARS Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 17.00 and a low estimate of 10.00. The median estimate represents a +96.91% increase from the last price of 7.11.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in ARS Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$100.0K
Reporting Date
Mar 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 74.00%
 
 
 
 
 
 
Growthannually 63.28%
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.